Details for Patent: 8,808,737
✉ Email this page to a colleague
Which drugs does patent 8,808,737 protect, and when does it expire?
Patent 8,808,737 protects OPANA ER and is included in two NDAs.
Summary for Patent: 8,808,737
Title: | Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment |
Abstract: | The invention pertains to a method of using oxymorphone in the treatment of pain by providing a patient with an oxymorphone dosage form and informing the patient or prescribing physician that the bioavailability of oxymorphone is increased in patients with renal impairment. |
Inventor(s): | Ahdieh; Harry (Lincoln University, PA) |
Assignee: | Endo Pharmaceuticals Inc. (Malvern, PA) |
Application Number: | 12/716,973 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,808,737 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 8,808,737
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-001 | Jun 22, 2006 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Try a Trial | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-001 | Dec 9, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF ADMINISTRATION OF CONTROLLED RELEASE OXYMORPHONE | ⤷ Try a Trial | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-005 | Feb 29, 2008 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Try a Trial | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-002 | Dec 9, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF ADMINISTRATION OF CONTROLLED RELEASE OXYMORPHONE | ⤷ Try a Trial | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-002 | Jun 22, 2006 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Try a Trial | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-003 | Dec 9, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF ADMINISTRATION OF CONTROLLED RELEASE OXYMORPHONE | ⤷ Try a Trial | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-006 | Feb 29, 2008 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |